-transparent.png){kind=logo}
A murine monoclonal antibody (WI-5) was produced against a myeloid leukemia cell line (KG-1). The antibody was immunoglobulin G3K. It reacted only against KG-1 cells and failed to react against 33 other cell lines representing fibroblasts, solid tumors, and cells of myeloid and lymphatic origin. It also showed no reaction against normal red blood cells, granulocytes, platelets, monocytes, and T- and B-lymphocytes. Similarly, there was no reaction against lymphocytes transformed by mitogens. Peripheral blood and bone marrow samples from acute granulocytic and acute lymphocytic leukemia, chronic granulocytic leukemia, chronic granulocytic leukemia in blastic crisis, and chronic lymphocytic leukemia failed to react with WI-5. It was suggested that WI-5 detected a unique antigen on KG-1 cells.
F Aota, and
D Chang, and
N O Hill, and
A Khan
December 1990,
Nihon juigaku zasshi. The Japanese journal of veterinary science,
F Aota, and
D Chang, and
N O Hill, and
A Khan
January 1992,
Journal of neuro-oncology,
F Aota, and
D Chang, and
N O Hill, and
A Khan
February 1991,
Molecular pharmacology,
F Aota, and
D Chang, and
N O Hill, and
A Khan
August 2019,
Journal of cellular physiology,
F Aota, and
D Chang, and
N O Hill, and
A Khan
March 2011,
Oncogene,
F Aota, and
D Chang, and
N O Hill, and
A Khan
January 2003,
Current hematology reports,
F Aota, and
D Chang, and
N O Hill, and
A Khan
February 2011,
Hybridoma (2005),
F Aota, and
D Chang, and
N O Hill, and
A Khan
January 1985,
Archiv fur Geschwulstforschung,
F Aota, and
D Chang, and
N O Hill, and
A Khan
January 2002,
Leukemia research,
F Aota, and
D Chang, and
N O Hill, and
A Khan
December 2006,
Blood,
